Menu Back to DIA-Meeting-on-Personalized-Medicines-and-Companion-Diagnostics

Program Committee

  • Jennifer  Paine, MS, RAC
    Jennifer Paine, MS, RAC Executive Vice President, Worldwide Quality, Regulatory and Compliance
    Ortho Clinical Diagnostic, United States
  • Steven B. Binion
    Steven B. Binion Director, Policy, Technology, and Communication - Corporate Regulatory Affairs
    Becton Dickinson, United States
  • Jennifer  Dudinak, PharmD
    Jennifer Dudinak, PharmD Senior Vice President, Global Regulatory Affairs
    Celgene Corporation, United States
  • Azin  Shahzamani
    Azin Shahzamani Senior Director, Regulatory Affairs
    Genentech, A Member of the Roche Group, United States
  • Jeffrey N. Stuart, PhD
    Jeffrey N. Stuart, PhD Executive Director, Global Regulatory Affairs
    Merck & Co., Inc., United States
  • Bradley Merrill Thompson
    Bradley Merrill Thompson General Counsel, Combination Products Coalition
    Epstein, Becker and Green P.C., United States
  • John Barlow Weiner, JD
    John Barlow Weiner, JD Associate Director for Policy, Office of Combination Products, OSMP
    FDA, United States
Load More

Digital Learning Catalog

DIA Learning: eLearning Soultions